entity

SIDE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SIDE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections
1Hypotheses
6Analyses
2Outgoing
0Incoming

Wiki Pages (20)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

Clinical Management Guide for CBS/PSP

therapeutic · 15224 words

Progressive Supranuclear Palsy (PSP)

disease · 12907 words

Corticobasal Syndrome (CBS)

disease · 11374 words

Outgoing (2)

TargetRelationTypeStr
STX17phosphorylatesprotein0.85
SNAP29phosphorylatesprotein0.85

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Ganglioside Rebalancing Therapy 0.496 neurodegeneration Lipid raft composition changes in synapt

Mentioning Analyses (6)

Scientific analyses that reference this entity

Why does PRKN-mediated mitophagy, typically protective, cause harmful mitochondr

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.455

Does TRT-induced erythrocytosis actually increase venous thromboembolism risk in

endocrinology | 2026-04-13 | 2 hypotheses Top: 0.572

Which tau propagation mechanism predominates in different brain regions and dise

neurodegeneration | 2026-04-07 | 0 hypotheses

Lipid metabolism dysregulation and membrane integrity in Alzheimer disease

neurodegeneration | 2026-04-04 | 0 hypotheses

CRISPR-based therapeutic approaches for neurodegenerative diseases

neurodegeneration | 2026-04-03 | 14 hypotheses Top: 0.622

Related Papers (15)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Genetic variants in ganglioside synthesis enzymes associate with Alzheimer's dis [PMID:synthetic_29] Unknown Nat Genet 2024 0
CSF ganglioside ratios predict Alzheimer's disease progression and correlate wit [PMID:synthetic_27] Unknown JAMA Neurol 2023 0
Small-molecule modulation of ganglioside synthesis normalizes brain lipid compos [PMID:synthetic_26] Unknown Nat Neurosci 2023 0
Glycosphingolipid-Glycan Signatures of Acute Myeloid Leukemia Cell Lines Reflect [PMID:35168327] ["Wang D", "Zhang T", "Maduni\u0107 K", Journal of proteome research 2022 0
Brain ganglioside composition is dysregulated in Alzheimer's disease with GM1 de [PMID:synthetic_24] Unknown Ann Neurol 2022 0
GM1 enhances BDNF-TrkB signaling and neuroprotection via lipid raft organization [PMID:synthetic_28] Unknown Mol Psychiatry 2022 0
GM1 ganglioside reduces amyloid-β aggregation and neurotoxicity in vitro [PMID:synthetic_23] Unknown J Neurosci 2021 0
Ganglioside composition varies widely across brain regions and cell types [PMID:synthetic_32] Unknown J Lipid Res 2021 0
Exogenous GM1 administration improves cognition and reduces pathology in APP/PS1 [PMID:synthetic_25] Unknown Neurobiol Aging 2020 0
Exogenous GM1 shows limited CNS bioavailability in clinical trials for Parkinson [PMID:synthetic_30] Unknown Mov Disord 2019 0
Ganglioside synthesis inhibitors cause peripheral neuropathy in Gaucher disease [PMID:synthetic_31] Unknown Ann Neurol 2018 0
Dynamism in gene expression across multiple studies. [PMID:19920211] ["Morgan A", "Dudley J", "Deshpande T", Physiological genomics 2010 0
Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricu [PMID:16505173] ["Pilichou K", "Nava A", "Basso C", "Bef Circulation 2006 0
Epidermal growth factor receptor as a therapeutic target in human thyroid carcin [PMID:16822827] ["Mitsiades C", "Kotoula V", "Poulaki V" The Journal of clinical endocr 2006 0
Re: Use of an Amplatz Goose Neck Snare as a target for collateral neck vein dial [PMID:11585895] Funaki B, Zaleski GX Journal of vascular and interv 2001 0